SCHEMBL25738484

SCHEMBL25738484

Cc1c(F)c2ccc(Br)cc2[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.47
▸ HPGD P15428 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PTGES O14684 2/20 0.41
▸ PARP1 P09874 1/20 0.40
▸ CDK9 P50750 2/20 0.40
▸ CDK5 Q00535 2/20 0.40
▸ CAMK2A Q9UQM7 2/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25738485 0.78 PARP1 (0.38) HPGDKDM4EALDH1A1GLAGAA
SCHEMBL17941961 0.77 METAP2 (0.47) METAP2KDM4EALDH1A1MAPTCDK9
SCHEMBL31212369 0.77 METAP2 (0.47) METAP2KDM4EALDH1A1MAPTCDK9
SCHEMBL31353096 0.76 GPR17 (0.45) METAP2KDM4EALDH1A1HTTPARP1
SCHEMBL25986282 0.76 CDK4 (0.44) METAP2HPGDKDM4EALDH1A1LMNA
SCHEMBL8162707 0.74 RAB9A (0.48) METAP2HPGDKDM4EALDH1A1MAPT
SCHEMBL17942005 0.73 METAP2 (0.41) METAP2MAPTPARP1CDK4CCND1
SCHEMBL10153752 0.73 PARP1 (0.56) METAP2HPGDKDM4EALDH1A1LMNA
SCHEMBL2798886 0.72 KDM4E (0.62) METAP2HPGDKDM4EALDH1A1GLA
SCHEMBL29892996 0.72 KDM4E (0.62) METAP2HPGDKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109521-A1 PARP INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 凯复(苏州)生物医药有限公司 2023-06-22 — — WO disclosed
Send feedback